Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Oliver

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Surgical Clinics of North America|April 10, 2022
Modern Approach to the Neck MassGabriela Heslop, Christopher L Oliver
Molecular Cancer Therapeutics|November 16, 2004
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptidesSanjeev Shangary, Christopher L Oliver, Tommy S Tillman, et al.
Molecular Cancer Therapeutics|January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistanceChristopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
The Laryngoscope|November 26, 2008
Palatal flap modifications allow pedicled reconstruction of the skull baseChristopher L Oliver, Trevor G Hackman, Ricardo L Carrau, et al.
The Laryngoscope|September 9, 2010
Pedicled facial buccinator (FAB) flap: a new flap for reconstruction of skull base defectsCarlos M Rivera-Serrano, Christopher L Oliver, John Sok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cellsChristopher L Oliver, Joshua A Bauer, Keith G Wolter, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Surgical Clinics of North America|April 10, 2022
Modern Approach to the Neck MassGabriela Heslop, Christopher L Oliver
Molecular Cancer Therapeutics|November 16, 2004
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptidesSanjeev Shangary, Christopher L Oliver, Tommy S Tillman, et al.
Molecular Cancer Therapeutics|January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistanceChristopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
The Laryngoscope|November 26, 2008
Palatal flap modifications allow pedicled reconstruction of the skull baseChristopher L Oliver, Trevor G Hackman, Ricardo L Carrau, et al.
The Laryngoscope|September 9, 2010
Pedicled facial buccinator (FAB) flap: a new flap for reconstruction of skull base defectsCarlos M Rivera-Serrano, Christopher L Oliver, John Sok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cellsChristopher L Oliver, Joshua A Bauer, Keith G Wolter, et al.
Pageof 1